Continuous renal replacement therapy in patients with hepatic and acute renal failure

American Journal of Kidney Diseases

Volumn 28, Issue 5 SUPPL. 3, 1996, Pages

  Davenport, A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

CRRT; liver failure; renal failure

Indexed keywords

DIALYSIS FLUID; HEPARIN; POLYACRYLONITRILE; POLYSULFONE;

ANTICOAGULATION; ARTICLE; BIOCOMPATIBILITY; BLOOD PUMP; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; DIALYSATE; DIALYSIS; DIALYSIS MEMBRANE; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; LIVER FAILURE; LIVER TRANSPLANTATION;

EID: 0029855244     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90081-5     Document Type: Article

References (13)

1. Davenport A, Kirby SA: Intensive care management of patients with acute hepatic and renal failure. Contrib Nephrol 116:22-27, 1995
2. Rakela J, Kurtz SB, McCarthy JT, Krom RAF, Baldus WP, McGill DB, Perrault J, Milliner DS: Postdilution hemofiltration in the management of acute hepatic failure: A pilot study. Mayo Clin Proc 63:113-118, 1988
3. Wendon JA, Harrison PM, Keays R, Gimson AES, Alexander GJM, Williams R: Effects of vasopressor agents and epoprostenol on systemic haemodynamics and oxygen transport in fulminant hepatic failure. Hepatology 15:1067-1071, 1992
4. Lee WM: Acute liver failure. Am J Med 96:3S-9S, 1994
5. Davenport A, Will EJ, Davison AM: Early changes in intracranial pressure during haemofiltration treatment in patients with grade IV hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transplant 5:192-198, 1990
6. Davenport A, Will EJ, Davison AM: Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal failure and hepatic failure. Nephron 66:431-437, 1994
7. Davenport A, Will EJ, Davison AM: Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int 43:S245-S251, 1993 (suppl 41)
8. Davenport A: Hemofiltration in patients with fulminant hepatic failure. Lancet 2:1604, 1991
9. Davenport A, Will EJ, Davison AM: Membrane biocompatibility: Effects on cardiovascular stability in patients on haemofiltration. Kidney Int 43:8230-8234, 1993 (suppl 41)
10. Ellis AJ, Lever R, Wendon J, Langley P, Williams R: Continuous venovenous hemodialysis using heparin/albumin precirculation in fulminant hepatic failure. From the 8th European Congress of Intensive Care Medicine, Athens, Greece, October 18-22, 1995 (abstr)
11. Gretz N, Quintel M, Ragaller M, Odenwalder W, Bender HJ, Rohmeiss P, Strauch M: Low-dose heparinisation for anticoagulation in intensive care patients on continuous hemofiltration. Contrib Nephrol 116:130-135, 1995
12. Jeffrey RF, Khan AA, Douglas JT, Will EJ, Davison AM: Anti-coagulation with low molecular weight heparin (Fragmin) during continuous haemodialysis in the intensive care unit. Artif Organs 17:717-720, 1993
13. Davenport A, Will EJ, Davison AM: The prognostic value of a lactate infusion in patients with severe hepatorenal failure. Renal Failure 13:111-118, 1991